Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke

Objective Intravenous thrombolytic therapy has become the standard of treatment for eligible patients with ischemic stroke. However, outcomes after receiving intravenous thrombolytic therapy vary widely. This study aims to investigate determinants of 1-year clinical outcomes of intravenous thromboly...

Full description

Bibliographic Details
Main Authors: Mingfeng Zhai MD, Jinwei Yang MD, Xiaoyan Cao MD, Yingying Li MD, Hui Xu MD, Yu Wang MD
Format: Article
Language:English
Published: SAGE Publishing 2023-07-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296231187616